A breakthrough in connected prenatal care!
With FDA De Novo marketing authorization, the Pulsenmore ES empowers physicians with new flexibility and models of care- supporting hybrid prenatal pathways that combine at-home ultrasound with clinical supervision.
We’re preparing for a phased U.S. launch with leading clinical institutions-advancing access, continuity, and equity in prenatal care.